Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
University of California, San Francisco
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
City of Hope Medical Center
Dana-Farber Cancer Institute
Emory University
Medical University of Vienna
Essen Biotech
St. Jude Children's Research Hospital
Nationwide Children's Hospital
St. Jude Children's Research Hospital
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Children's Hospital Los Angeles
Stanford University
Baylor College of Medicine
Dana-Farber Cancer Institute
Augusta University
Augusta University
St. Jude Children's Research Hospital
University of Florida
St. Jude Children's Research Hospital
Masonic Cancer Center, University of Minnesota
Hadassah Medical Organization
Medical College of Wisconsin
New Approaches to Neuroblastoma Therapy Consortium
UNC Lineberger Comprehensive Cancer Center
Baylor College of Medicine
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
Baylor College of Medicine
New Approaches to Neuroblastoma Therapy Consortium
New Approaches to Neuroblastoma Therapy Consortium
St. Jude Children's Research Hospital
Institut Curie
Essen Biotech
University of Birmingham
University of Cologne
St. Jude Children's Research Hospital
Albert Einstein College of Medicine
OHSU Knight Cancer Institute
New Approaches to Neuroblastoma Therapy Consortium
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
OHSU Knight Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Cancer Research UK
St. Anna Kinderkrebsforschung
M.D. Anderson Cancer Center
Emory University